pioglitazone has been researched along with Inadequate Sleep in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y | 1 |
| Wang, J | 1 |
| Zhao, Q | 1 |
| Xie, X | 1 |
| Song, R | 1 |
| Xiao, Y | 1 |
| Kang, X | 1 |
| Zhang, L | 1 |
| Zhang, Y | 1 |
| Peng, C | 1 |
| You, Z | 1 |
1 other study available for pioglitazone and Inadequate Sleep
| Article | Year |
|---|---|
Pioglitazone alleviates maternal sleep deprivation-induced cognitive deficits in male rat offspring by enhancing microglia-mediated neurogenesis.
Topics: Animals; Cognition; Cognitive Dysfunction; Female; Hippocampus; Male; Microglia; Neurogenesis; Piogl | 2020 |